Nausheen Ahmed, MD
Advertisement
Nausheen Ahmed, MD, is an associate professor of hematologic malignancies and cellular therapeutics at the University of Kansas Medical Center.
Articles by Nausheen Ahmed, MD
Nausheen Ahmed, MD, discusses the guidelines for monitoring patients after receiving CAR T-cell therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Oncology Update January 2026: New Horizons in Precision Medicine
2
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
3
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5